WFDC2 and COVID-19: COVID-19 patients with highly elevated baseline HE4 levels (≥ 331.7 pmol/L) had a significantly higher risk for 30-day mortality compared to those with somewhat lower HE4 concentrations (Log rank P < 0.0001).